Interrogation of gossypol therapy in glioblastoma implementing cell line and patient-derived tumour models

BACKGROUND: Glioblastoma (GBM), being a highly vascularised and locally invasive tumour, is an attractive target for anti-angiogenic and anti-invasive therapies. The GBM/endothelial cell response to gossypol/temozolomide (TMZ) treatment was investigated with a particular aim to assess treatment effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Jarzabek, M A, Amberger-Murphy, V, Callanan, J J, Gao, C, Zagozdzon, A M, Shiels, L, Wang, J, Ligon, K L, Rich, B E, Dicker, P, Gallagher, W M, Prehn, J H M, Byrne, A T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264441/
https://www.ncbi.nlm.nih.gov/pubmed/25375271
http://dx.doi.org/10.1038/bjc.2014.529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264441/
https://www.ncbi.nlm.nih.gov/pubmed/25375271
http://dx.doi.org/10.1038/bjc.2014.529

Ejemplares similares